Skip to main content
Number №4, 2025
Legal Sovereignty of the Individual in Digital Healthcare in the Era of Artificial Intelligence
Number №3, 2025
Digital Health: Forecast for 2025-2030
Number №2, 2025
Digital technologies in remote monitoring of childbirth with a Clinical decision support system (CDSS)
Number №1, 2025
Digital technologies for health promotion and disease prevention in older adults
Number №4, 2024
Computer reconstruction of the interaction of genes associated with Angelman syndrome
Number №3, 2024
Telemedicine today: trends in the use of telemedicine consultations based on regional experience
Number №2, 2024
Mobile apps for psychological well-being: user attitudes and definition of requirements
Number №1, 2024
Diagnosis in the era of digital medicine
Number №4, 2023
Artificial intelligence in Russian healthcare: collecting and preparing data for machine learning
Number №3, 2023
China as a supplier of medical equipment in the Russian Federation. Options for cooperation and features of working with Chinese suppliers
Number №2, 2023
Experience in teaching telemedicine in the system of higher professional education The attitude of medical workers to telemedicine technologies
Number №4, 2022
Physician burnout: the hidden healthcare crisis. Results of an online survey of doctors
Number №3, 2022
Interaction of clinical and diagnostic medicine. Results of an online survey of doctors
Number №2, 2022
Mobile applications for mental health self-management: a review of customers’ opinions Ultrasound robots: ready-to-use solutions and perspective directions
Number №1, 2022
Digital transformation of the pathological service as a way to improve the quality of medical care
Number №4, 2021
Clinical guidelines of the Ministry of Health of the Russian Federation: are doctors ready to follow them? Results of an online survey of doctors.
Number №3, 2021
Виртуальная реальность (VR) в клинической медицине: международный и российский опыт
Number №2, 2021
Дистанционные консультации пациентов: что изменилось за 20 лет?
Number №1, 2021
Experience of participation in the blood pressure telemonitoring pilot project of the Ministry of Healthcare
Number №4, 2020
Автоматизация процесса выявления у беременных заболевания COVID-19
Number №3, 2020
Remote cognitive behavioral therapy for stress disorder associated with the COVID-19 pandemic
Number №2, 2020
Distance education at a medical school during the COVID-19 pandemic: the first experience through the eyes of students
Number №1-2, 2018
Ответственность при использовании телемедицины: врач или юрист Скрининг меланомы: искусственный интеллект, mHealth и теледерматология
Number №3, 2018 год
II Всероссийский форум по телемедицине, цифровизации здравоохранения и медицинскому маркетингу «ТЕЛЕМЕДФОРУМ 2019» Эффективность телемедицинских консультаций «пациент-врач» Телереабилитация: рандомизированное исследование исходов
Number №1-2, 2019
Роль искусственного интеллекта в медицине Информационная система поддержки принятия врачебных решений
Number №1, 2020
Technologies for continuous monitoring of blood pressure: prospects for practical application Telemedicine technologies in the Chinese army
Number №2, 2017
Primary telemedicine consultation "patient-doctor": first systematization of methodology
Number №1, 2017
1. A systematic review of using Internet messengers in telemedicine 2. Telemedicine and social networks in the fight against drug addiction
Number №1, 2016
1. The Experience of the Telehealth Network of Minas Gerais, Brazil 2. The Remote Monitoring of Patients with Congestive Heart Failure:The Organizational Impact..
Number №1, 2015
Teleassessment for diagnosis and treatment in urology Efficiency of telemedicine at the northern regions Russian Federation A.L. Tsaregorodtsev

Development of a visualization model for immunological parameters to predict the severity of cardiovascular diseases

Number №4, 2025 - page 17-25
DOI: 10.29188/2712-9217-2025-11-4-17-25
For citation: Krylov A.S., Myagkova M.A., Bobrova Z.V., Petrochenko S.N. Development of a visualization model for immunological parameters to predict the severity of cardiovascular diseases. Russian Journal of Telemedicine and E-Health 2025;11(4):17-25; https://doi.org/10.29188/2712-9217-2025-11-4-17-25
Krylov A.S., Myagkova M.A., Bobrova Z.V., Petrochenko S.N.
Information about authors:
  • Krylov A.S. – Junior Researcher, DIANARK LLC; Moscow, Russia; https://orcid.org0000-0001-7085-3437
  • Myagkova M.A. – Dr. Sci. (Biol.), Professor, Leading Researcher, Institute of Physiologically Active Compounds, Federal Research Center for Problems of Chemical Physics and Medicinal Chemistry, Russian Academy of Sciences; Chernogolovka, Moscow Region, Russia; https://orcid.org0000-0001-7831-7663
  • Bobrova Z.V. – Researcher, DIANARK LLC; Moscow, Russia; https://orcid.org0000-0002-8073-8763
  • Petrochenko S.N. – general director DIANARK LLC; Moscow, Russia; https://orcid.org/0000-0003-3656-9007
223
Download PDF

Introduction. This study presents the practical application of a developed software suite designed for the visualization and analysis of immunological parameters in patients with cardiovascular diseases (CVD). The core of the software is an original three-dimensional mathematical balance model that integrates laboratory immunochemical data into an interactive graphical system. Visualization is achieved through dynamic changes in the tilt angle of a virtual platform, reflecting the cumulative state of key immunological parameters associated with CVD pathogenesis.

Materials and methods. We investigated the levels of natural antibodies (n-Abs) to key bioregulators—serotonin, dopamine, histamine, and angiotensin II—in patients with various forms of CVD. The analysis included three groups: 1) patients with arterial hypertension (n=45), 2) patients with combined pathology (hypertension and coronary artery disease, n=53), and 3) a control group (n=41). Antibody levels were determined using ELISA.

Results. A statistically significant increase in n-Ab levels was observed in all patient groups compared to controls, with the most pronounced changes in patients with mixed pathology. A mathematical balance model was proposed to integrate laboratory data and predict CVD severity. The results were validated by clinical assessments of the examined patients.

Conclusions. The developed software features a user-friendly interface, adjustable settings, and a scale for measuring the platform’s tilt angle. This system can be applied in telemedicine for disease progression prediction and clinical decision support.

Attachment Size
Download 511.4 KB
Keywords: software suite; mathematical model; immunochemical analysis; natural antibodies; data visualization; telemedicine; cardiovascular diseases; balance model